KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Exact Sciences (EXAS) over the last 15 years, with Sep 2025 value amounting to $5.9 billion.

  • Exact Sciences' Liabilities and Shareholders Equity fell 12.57% to $5.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 billion, marking a year-over-year decrease of 11.16%. This contributed to the annual value of $5.9 billion for FY2024, which is 8.39% down from last year.
  • Exact Sciences' Liabilities and Shareholders Equity amounted to $5.9 billion in Q3 2025, which was up 1.77% from $5.8 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Liabilities and Shareholders Equity ranged from a high of $6.7 billion in Q3 2024 and a low of $5.7 billion during Q1 2025.
  • Its 3-year average for Liabilities and Shareholders Equity is $6.2 billion, with a median of $6.4 billion in 2023.
  • Per our database at Business Quant, Exact Sciences' Liabilities and Shareholders Equity spiked by 52.82% in 2021 and then declined by 13.13% in 2025.
  • Over the past 5 years, Exact Sciences' Liabilities and Shareholders Equity (Quarterly) stood at $6.7 billion in 2021, then declined by 6.85% to $6.2 billion in 2022, then rose by 3.93% to $6.5 billion in 2023, then fell by 8.39% to $5.9 billion in 2024, then decreased by 12.57% to $5.9 billion in 2025.
  • Its last three reported values are $5.9 billion in Q3 2025, $5.8 billion for Q2 2025, and $5.7 billion during Q1 2025.